Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Muscle involvement in limb-girdle muscular dystrophy with GMPPB deficiency (LGMD2T)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Migraine polygenic risk score associates with efficacy of migraine-specific drugs

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Homozygosity for SCN4A Arg1142Gln causes congenital myopathy with variable disease expression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clinical heterogeneity and phenotype/genotype findings in 5 families with GYG1 deficiency

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Phenotypic Spectrum of α-Dystroglycanopathies Associated With the c.919T>a Variant in the FKRP Gene in Humans and Mice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Vacuoles, Often Containing Glycogen, Are a Consistent Finding in Hypokalemic Periodic Paralysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: In this study, muscle involvement assessed by MRI and levels of GMPPB and glycosylation of α-dystroglycan expression in muscle were examined in patients with limb-girdle muscular dystrophy (LGMD) type 2T.

METHODS: Six new patients with genetically verified mutations in GMPPB were studied. T1-weighted magnetic resonance images were obtained in 4 participants. Muscle strength and potential involvement of extramuscular organs were examined. Glycosylation of α-dystroglycan in muscle was studied, and GMPPB and α-dystroglycan expression was analyzed by Western blotting. Prevalence of LGMD2T was calculated from the total LGMD population in Denmark. GMPPB was sequenced in all unclassified cases.

RESULTS: Two patients carried 3 new mutations in GMPPB. The other 4 patients carried previously described pathogenic mutations in GMPPB. MRI showed that the paraspinal muscles were the most affected, followed by involvement of hamstrings. Our results showed a loss of glycosylation of α-dystroglycan as well as secondary loss of merosin expression on Western blotting. The prevalence of LGMD2T in the Danish cohort of patients with LGMD is 1.5%.

CONCLUSIONS: The new findings of this study are (1) the consistent finding of a preferential affection of paraspinal and hamstring muscles in LGMD2T, (2) 3 new mutations in GMPPB, (3) variable loss of glycosylation tested with IIH6 and VIA4 antibodies, and (4) a prevalence of LGMD2T of 1.5% in a well-characterized Danish LGMD cohort.

OriginalsprogEngelsk
TidsskriftNeurology. Genetics
Vol/bind2
Udgave nummer6
Sider (fra-til)e112
ISSN2376-7839
DOI
StatusUdgivet - dec. 2016

ID: 49294832